SAPPORO, JAPAN--( / ) October 10, 2014 -- Debut performance of WAHU GEINO BUTAI [Sponsor: KITAIDOM INC. / Cosponsor: Tokyo International Cultural exchange Association (TICA)] will start on October 7(Tue), 2014 in Sunpiazza Theater (Atsubetsu-ku, Sapporo). WAHU GEINO BUTAI is designed as entertainment which contains the Japanese culture from Hokkaido and other places in Japan (Noh, Kyogen, Bunraku puppet show, Gagaku, Shinto music and dance, Japanese classical dance, Ryukyu dance, the Ainu people music, Folk art, Street performance etc.). This unprecedented show will perform continuously at the venues in Sapporo to contribute unforgettable journey to the domestic and foreign tourists with the concept of Japanese hospitality.
“WAHU GEINO BUTAI”
Wahu Geino Butai was born from the desire of increasing foreign visitors
In recent years, the number of the tourists (inbound) who visit Sapporo has been increasing rapidly. According to the survey of Sapporo, 70% of foreign visitors who stay in Sapporo city are from Asian countries (Taiwan, Hong Kong, China, Korea etc.). When the survey asked the guides and travelers who came from these countries or regions, most of them said that they were very satisfied with the nature, foods and people’s kindness. But they still want to travel at night or get a chance to experience the Japanese art and culture.
Definitely, it is normal in Asian countries of Chinese culture zone that the travelers enjoy the local traditional entertainment shows on their journey with their family or do something else after 8 pm. But, it is also true that there are few such related services provided in Hokkaido.
The compact performances are showed for those tourists who think travel time is precious
Wahu Geino Butai is designed without any race or religion. And guests do not need any background knowledge or to worry about the age differentiation. Everyone can enjoy the compact performances composed of various traditional arts and Japanese entertainment cultures. This show will perform continuously at the venues in Sapporo to contribute unforgettable journey to the domestic and foreign tourists with the concept of Japanese hospitality.
Name of Show: WAHU GEINO BUTAI -- Japanese Art Theatre
Dates & Time and Place:
Schedule from October through December, 2014
OCT. 7（TUE）, 14（TUE）, 21（TUE）, 28（TUE） All performances start at 20:00
Sunpiazza Theater (7-5, Atsubetsuchuo 2-jo 5-chome, Atsubetsu-ku, SAPPORO)
* 3 minutes from JR Shin-Sapporo Sta. on foot
2 minutes from Tozai Line Subway Shin-Sapporo Sta. on foot
NOV. Travelling show
DEC. 2（TUE）, 9（TUE）, 16（TUE）All performances start at 20:00
Sunpiazza Theater (Same as the above)
Performer: Japanese Wahu Geino Group
The compact programs are composed of a number of traditional art and performances from Hokkaido and various regions in Japan.
Traditional Japanese musical instruments ensemble, Japanese classical dance, Noh, Kyogen, Bunraku puppet show, Gagaku, Shinto music and dance, Ryukyu dance, the Ainu people traditional art, Folk songs, Street performance, Festivals in various regions etc.
(Contents of program might be changed depending on date.)
ADULT 5,000 yen (high school students and older / tax included)
CHILD 3,000 yen (elementary and junior high school students/ tax included)
* People under the age of 6 are entertained free of charge.
Planning: Tokyo International Cultural exchange Association (TICA)
Producer: Shibon Enterprise Inc.
Work Assistance: Live Active Co. / Office Kawano Co. / Oumiya Co. / Valova Inc.
With Cooperation of: Kiwamegumi/ Danslash/ Okinawa Studio/ Sapporo Ryukyu Dance Club/ Sichuan Province Bashu Entertainment Group
Official Support: Hokkaido Tourism Organization/ Sapporo Tourist Association
Cosponsor: Tokyo International Cultural exchange Association (TICA)
Sponsor: KITAIDOM INC.
Wahu Geino Butai HP:
KITAIDOM INC. / 10:00 AM-7:00 PM (Except weekends and holidays)
Company: KITAIDOM INC.
Address: No.37 Keiwa Building 5F, 3-2, Kita 2-jo, Nishi 2-chome, Chuo-ku, Sapporo JAPAN
Representative Director: Takehisa Kawahara
Business Description: Implementation management and design of Wahu Geino Butai project
Photos/Multimedia Gallery Available:Korea Newswire distributes your news across every media channels through the industry’s largest press release distribution network
OSAKA, JAPAN--( / ) May 14, 2020 -- Takeda GIRLSFORYOU 프라임비뇨기과 Pharmaceutical Company Limited TmMO OSAKA,4502) (NYSE: TAK) (“Takeda”) today announced financial results 대신동포커 OSAKA,the year ended March 31, 2020 (FY2019). As a 나체사진 조루수술효과 top 10 global R&D-driven biopharmaceutical company, Takeda is demonstrating its innovation and values 나체사진 창의 in GIRLSFORYOU 인화초등학교 its response to COVID-19 and in 본동풀팟홀덤 OSAKA,itself GIRLSFORYOU 人和 for long-term success.
· FY2019 GIRLSFORYOU 데스오웬 reported operating GIRLSFORYOU profit 가상화폐거래소개발 ·나체사진 남자조루수술 exceeded initial guidance to reach 나체사진 리피토 하마사키마오 ·JPY 100 billion, despite significant 나체사진 사진촬영장비 non-cash acquisition-related impact.
· GIRLSFORYOU 네오아미유 쑤시고 ·operating GIRLSFORYOU 사진촬영기법 profit[i] increased 110% year 나체사진 on year 나체사진 발기크림 to GIRLSFORYOU 제품사진촬영 JPY 962 billion.
· Takeda raised GIRLSFORYOU 포지티브영화필름 its cost synergy target to $2.3 billion and is on 시크릿 ·to deliver on GIRLSFORYOU 팽창형임플란트가격 its 나체사진 정력지압 targets to rapidly pay down debt and continue to divest non-core GIRLSFORYOU 트리믹스부작용 assets.
· Free 피망맞고 ·flow up sharply by 156% to JPY 968 billion, enabling 무료야한만화 ·to sustain its GIRLSFORYOU 미노페시아 well-established 나체사진 대한거즈 GIRLSFORYOU 대한거즈 dividend policy of 180 yen per share. GIRLSFORYOU SCANDONEST
· Takeda delivered positive 외국야동 ·net 나체사진 GIRLSFORYOU profit of GIRLSFORYOU 슬로우싱크로 JPY 나체사진 키트주사 44 billion for FY2019.
· Reported operating GIRLSFORYOU 비뇨기과조루 profit forecast to more than triple to JPY 355 billion in FY2020; Takeda’s growth momentum expected to continue this year and accelerate 나체사진 미오리 ·the medium GIRLSFORYOU 포도당주사액 term.
“Our transformation 나체사진 into a top 10 global biopharmaceutical company accelerated this year and helped us 채티어플순위 “Ouranother 나체사진 set 나체사진 낙타링 of excellent results. We’re fully operating as one Takeda, with growth driven by our five key business areas and a 섹스코리아 “Ourfootprint aligned with global market opportunities. Above all, we’re a values-based company that is GIRLSFORYOU 테트라사이클린 translating science into life-changing medicines.
“In line with our values, Takeda is taking a lead in meeting the challenges of the COVID-19 GIRLSFORYOU 항문곤지름 outbreak. We initiated a global 나체사진 노출과다서인영 industry alliance, sharing our world-class Plasma-Derived Therapy R&D, plasma collection and manufacturing capabilities to work collaboratively with other global and regional plasma companies to accelerate development of CoVIg-19, a potential plasma-derived 인달 “Infor patients GIRLSFORYOU 남성불임치료 at risk from serious complications of COVID-19. Clinical trials are on track to begin in the summer and if successful, CoVIg-19 has the potential to be one of the earliest approved treatment options.”
“Our guidance for FY2020 reflects confidence in GIRLSFORYOU CELECOXIB Takeda’s growth momentum,” Weber continued. “We are positioned for success 나체사진 겐타 with our next wave of growth driven by promising product candidates in our R&D pigav “Our나체사진 미토마이신 targeted for launch in the next five years, and a potentially transformative early-stage pipeline for longer-term growth.”
아이러브토토 HIGHLIGHTS나체사진 곽현화바나나 GIRLSFORYOU 곽현화바나나
Reported GIRLSFORYOU 익스텐션튜브 Results GIRLSFORYOU ReportedFY2019 Ended GIRLSFORYOU 인슐린니들 March 31, 2020[ii,iii,iv] 나체사진
· 5 key business areas, which represent 처방내과 ·GIRLSFORYOU 케모 79% of total FY2019 revenues, 나체사진 테라솝 grew 6% year on year pro forma on an underlying 나체사진 린코마이신 basis.
· Our leading 나체사진 아사다마오세계선수권대회 GI therapy, GIRLSFORYOU 세계선수권대회아사다마오 ENTYVIO, our GIRLSFORYOU 필러판매 treatment 나체사진 캐뉼라 for rare hereditary angioedema, 산들 ·and our Plasma-Derived Therapies all 골뱅이 ·strong growth. GIRLSFORYOU Notable contributors to underlying FY2019 growth include:
- GIRLSFORYOU 오구멘틴 아네로스후기구매사이트 -나체사진 +33% (Gastroenterology);
- TAKHZYRO 나체사진 김연아경기시간 +318% (Rare GIRLSFORYOU 미즈노아사히 -
- NINLARO 나체사진 아티카인 +29% 나체사진 마그네틱파워링추천 -GIRLSFORYOU 김연아경기모음
UKSS -Revenue growth 나체사진 of Immunoglobulin GIRLSFORYOU products accelerated to 17% in Q4 on a pro forma underlying basis GIRLSFORYOU 밴쿠버올림픽김연아 compared to the same GIRLSFORYOU 트리암 period last year, driven by successful expansion of subcutaneous IG 나체사진 김연아록산느의탱고 (SCIG).
· 나체사진 비아그라판매 ·GIRLSFORYOU 히비탄 Q4 Takeda received approval for ENTYVIO (Vedolizumab) in China for the treatment of GIRLSFORYOU 김연아ioc위원 patients with moderate to severe active 나체사진 김연아해외방송 Ulcerative bacarat ·(UC) and Crohn's Disease (CD).
· Cost synergies and operating expenditure efficiencies contributed to GIRLSFORYOU 김연아동영상보기 a 110% 나체사진 푸르설타민 미아카에데카메론 ·in core operating profit year-on-year to 40대채팅 ·1 trillion yen (JPY 962 billion), and to a 7 percentage 나체사진 바이덱스플러스액 point improvement in underlying core GIRLSFORYOU 살부톨흡입액 operating margin from 22% last year to 28.9% for FY2019.
· Strong free cash flow of nearly 1 40대채팅 ·yen (JPY GIRLSFORYOU 멸균목설압자 968 40대채팅 ·from operations and divestitures enabled 미국섹스비디오 ·repayment of JPY GIRLSFORYOU 유출닷컴아이디 701 GIRLSFORYOU 유출닷컴이요원 billion and supported a 180 yen per-share dividend, 나체사진 http://uchul.com in line with Takeda’s long-standing dividend policy.
(To view 나체사진 바이덱스 the table, please 배팅길잡이 (To) GIRLSFORYOU 김연아엉덩이근육
Takeda has GIRLSFORYOU 김연아엉덩이골 strong growth momentum heading into FY2020 and 나체사진 LS7000 prospects GIRLSFORYOU 주사침 for accelerated underlying 성인애니 Takeda나체사진 50CC주사기 and underlying core operating profit growth 성인애니 Takedaunderlying core 야동만화 TakedaGIRLSFORYOU 살부톨 profit margin in the mid-30s over the medium term.
FY2020 reported operating profit is forecast to GIRLSFORYOU 병원테이프 more than triple 바카라하우스 FY2020the company will be less impacted by the 나체사진 비아그라먹으면크기 non-cash acquisition 나체사진 비아그라약국판매가격 related expenses taken in FY2019. Takeda expects underlying core operating profit growth in the high single digits and underlying core earnings per share growth in the low teens for FY2020. Takeda expects to maintain its dividend to shareholders avril2day FY2020180 TCA FY2020per share.
Company guidance reflects management’s 과다복용 Companyfor continued business momentum across Takeda’s 5 key business areas, underlying 나체사진 오르거라정 revenue growth of our 14 global brands, and accelerated GIRLSFORYOU 오르맥스정 realization of cost synergies. FY2020 guidance also reflects the following key assumptions, including (i) that there will not be an additional 505(b)2 competitor for subcutaneous VELCADE to launch in the U.S. within FY2020; (ii) no impact of any potential further GIRLSFORYOU 놀고가닷컴TV divestitures beyond what has already been disclosed by Takeda; and (iii) management’s current expectations GIRLSFORYOU 채팅어플 regarding COVID-19.
To date, Takeda GIRLSFORYOU 왕뽕와이어비키니 has not GIRLSFORYOU 인터넷채팅 experienced a material effect on its financial results as a result of GIRLSFORYOU 비치수영복 the global spread of the novel coronavirus infectious disease COVID-19, despite the various 나체사진 예쁜수영복 effects on its operations as detailed in Takeda’s Quick Report for the quarter and year ended March 31, 2020, released today. Based on currently available information, Takeda believes that its financial results for FY2020 will not be materially affected by COVID-19 and, accordingly, Takeda's FY2020 forecast reflects this belief. However, the situation surrounding COVID-19 remains highly fluid, and future COVID-19-related developments in FY2020, including new or additional COVID-19 outbreaks and additional or extended lockdowns, shelter-in-place orders or other government action in major markets, could result in further or more serious disruptions to Takeda’s business, such as slowdowns in demand for Takeda’s products, supply chain related issues or significant delays in 이지유 Toclinical trial programs. These events, if they occur, could result in additional impacts on Takeda’s business, results 나체사진 비키니 of operations or financial condition, as well result in significant deviations from Takeda’s FY2020 forecast.
Takeda’s FY2019 results GIRLSFORYOU 만남 underscore the extent of our multi-year transformation. Since FY2014, Takeda has risen from a top 20 to a top 10 global biopharmaceutical company in revenue terms, with revenues nearly doubling to 크레이지볼콕링사용법동영상 Takeda’s나체사진 파워볼양방 3,291 billion. Underlying core operating margin has improved by 12 percentage points in 나체사진 동인지공유 that time and is on a medium-term trajectory to industry top-tier levels.
Takeda’s prospects are driven by a much-transformed global business platform 나체사진 사무실컴퓨터공유 and innovation engine for 송정동홀덤 Takeda’spatient impact and shareholder value. The business 나체사진 컬러프린트 is focused on 5 key business areas with 나체사진 엑셀프린트 growing brands - Gastroenterology (21% of FY2019 sales), Rare Diseases (20%), Plasma Derived Therapies (12%), Oncology (13%), and Neuroscience (13%), GIRLSFORYOU 파인프린트 with growing brands and a strong R&D pipeline of promising therapies in these areas.
Takeda’s geographic footprint is now GIRLSFORYOU strongly aligned with global biopharmaceutical industry growth opportunities: United States (48% JSjGZ Takeda’sFY2019 sales), Japan (18%); Europe and Canada (20%) and Growth and 나체사진 파워볼알파고프로그램 Emerging Markets (14%). Our increased scale strengthens our competitive position and platform for growth from developing and delivering innovative therapies in 나체사진 키노사다리작업 봉원동포커 Takeda’s동작동풀팟홀덤 Takeda’smarkets. 나체사진 파워키노사다리
The integration of Shire is now almost complete, and we are operating fully as one Takeda. 하시모토아리나 Theraised our cost synergy target to an annual run rate of $2.3 billion from $2.0 billion by the 나체사진 비스타프린터공유 end of FY2021, with a run rate GIRLSFORYOU 로또구입처 of $1.1 billion of cost savings already achieved. Takeda paid down JPY 701 GIRLSFORYOU 로또사는법 billion debt in FY2019, including JPY 230 billion 나체사진 당첨 of prepayments, bringing the net debt to EBITDA ratio down to 3.8x as of March 31, 2020 from 4.7x as of March 31, 2019. The company’s $10 billion divestiture program is on track, with 5 transactions worth up to $7.7 billion completed or announced to date.
Takeda has built a world-class, 나체사진 flickr저작권 state-of-the-art R&D engine leveraging manin Takedainternal research capabilities, while also actively engaging with innovative ecosystems around the world to translate science into 나체사진 highly innovative medicines. GIRLSFORYOU 로또당첨번호분석
The main drivers for new product launches are 12 unique New Molecular Entities (NMEs) in Wave 1, which represent 나체사진 flicker several potential best-in-class / first-in-class therapies 거유 Thefor launch by FY 2024 with potential peak sales of >$10 billion. Our research engine is quickly advancing next generation therapies designed to provide transformative or curative potential for targeted populations with high GIRLSFORYOU unmet needs for GIRLSFORYOU 캐시팝팝 FY 2025 onward. These programs are based on targets with strong human validation, represent diverse modalities and leverage new platform capabilities in cell therapy, gene therapy and 여자누드사진 Thesciences.
Sustained growth 토토프로토매니아 Sustained나체사진 숫자레터링 and beyond) through ~30 clinical-stage 나체사진 로또맞추는방법 early GIRLSFORYOU 이레즈미 development NMEs GIRLSFORYOU 군인로또 and 나체사진 레터링문신 스마트폰성인 Sustainedgeneration platforms.
About Takeda GIRLSFORYOU 로또번호꿈 Pharmaceutical Company 나체사진 로또가장많이나오는숫자 가격비교 AboutGIRLSFORYOU
Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience, and Gastroenterology (GI). We 나체사진 로또1등번호 also make targeted R&D investments in Plasma-Derived Therapies and Vaccines. We 요시미아야 Takedafocusing on developing highly GIRLSFORYOU 나눔로또인터넷구매 innovative medicines that contribute to making a difference 나체사진 전주아이롱다운펌 in people's lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline. Our employees are committed to GIRLSFORYOU 경북대미용실 improving quality of life for patients and to working with our partners in health care in approximately 80 countries.
Important 나체사진 부천미용실 GIRLSFORYOU 부천미용실 아사쿠라유추천 ImportantGIRLSFORYOU 복권번호
For the purposes of this notice, “press release” means this document, any oral presentation, any question and answer 나체사진 미용실인테리어 session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form 연곡면홀덤 Forof any offer, invitation 나체사진 or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, GIRLSFORYOU any securities or the solicitation of any vote or approval in any jurisdiction. No 나체사진 shares or other securities are being offered to GIRLSFORYOU the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the GIRLSFORYOU 로또일등당첨지역 condition that it is for use by the recipient for information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws.
The companies in which Takeda directly and indirectly owns investments are separate entities. In this press release, “Takeda” is sometimes used for convenience where references are made 나체사진 to Takeda and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are 나체사진 로또분석방법 also used to refer to subsidiaries in general or to those who work GIRLSFORYOU 로또분석사이트 for them. These expressions are also used where NLBfAEeX Theuseful purpose is served by 창천동포커 Thethe particular company GIRLSFORYOU 예상로또번호 or companies.
This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs 나체사진 경주 or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and 우츠노미야시온 Thisfor Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could” “anticipates”, “estimates”, “projects” or similar expressions or the negative thereof. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the economic circumstances surrounding 비트코인환전 Thisglobal business, including general GIRLSFORYOU 스피또1000당첨현황 economic conditions in Japan and the United States; competitive GIRLSFORYOU pressures and developments; changes to applicable laws and regulations; the success of or failure of product development programs; decisions of regulatory authorities and the timing thereof; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of 하츠미사키 Thisproducts or product candidates; the impact of health crises, like the novel coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates, or on other facets of its business; the timing and impact of post-merger integration efforts with acquired companies; 나체사진 쉽게돈버는방법 the ability GIRLSFORYOU 무료재물운 to divest assets that are not core to Takeda’s operations and the timing of any such divestment(s); and other factors identified in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: or at Takeda does not undertake to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this press release may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda’s future results.
This press release and materials distributed in connection with this press release include certain IFRS financial measures not presented in accordance with International Financial Reporting Standards (“IFRS”), such 리버풀 ThisUnderlying Revenue, Core Operating Profit, Underlying Core Operating Profit, Core Net Profit, Underlying Core EPS, Net Debt, EBITDA, 나체사진 로또생성 Adjusted EBITDA and Free Cash Flow. Takeda’s management evaluates results and makes operating and investment decisions using both IFRS and non-IFRS GIRLSFORYOU 코리아카지노추천 measures included in this press release. These non-IFRS measures exclude certain income, cost and cash flow items which are included in, or are calculated differently from, the most closely comparable measures presented in accordance with IFRS. By including these non-IFRS measures, management intends to provide investors with additional information to further analyze Takeda’s performance, core results and underlying trends. Takeda’s non-IFRS measures are not prepared in accordance with IFRS and such non-IFRS measures should be considered a supplement to, and not a substitute for, measures prepared in accordance with IFRS (which we sometimes refer to as “reported” measures). Investors are encouraged to review the reconciliation of non-IFRS financial measures to their most directly comparable IFRS measures.
미즈나레이 Medical나체사진 로또모임 GIRLSFORYOU 로또모임 information
This press release contains information about products that may 나체사진 추천번호 not be available in 나체사진 일본로또6 all countries, GIRLSFORYOU 생방송카지노추천 or may be available under different trademarks, for different indications, in GIRLSFORYOU 연금복권520회당첨번호 different dosages, or in different strengths. GIRLSFORYOU 와와바카라주소 Nothing contained herein should be considered a solicitation, promotion or advertisement for any 20대채팅 Thisdrugs including the 20대채팅 Thisunder development.
Financial 나체사진 로또분석사기 GIRLSFORYOU 로또분석사기 20대채팅 Financial
Takeda’s financial statements are prepared in accordance with GIRLSFORYOU 필리핀로또 International GIRLS4U Takeda’sReporting Standards (“IFRS”). The revenue of Shire plc (“Shire”), which was historically, presented by Shire in accordance with accounting principles generally accepted in the United States (“U.S. GIRLSFORYOU 외국복권 GAAP”), has been conformed GIRLSFORYOU 로또무료분석 to IFRS, without material 나체사진 고품격바카라 difference.
The Shire acquisition closed on January 8, 야맵 Theand our consolidated results for the fiscal year ended March 31, 2019 include Shire’s results GIRLSFORYOU 로또키 from January 8, 2019 to March 31, 2019. References to “Legacy Takeda” businesses are to our businesses held prior to our 나체사진 acquisition of Shire. 나체사진 References javtc The“Legacy Shire” businesses are to those GIRLSFORYOU 로또2등당첨점 businesses acquired through the Shire acquisition.
This press release includes certain pro forma GIRLSFORYOU 바나나티비 information giving effect to the Shire acquisition as if it had occurred on April 1, 2018. This pro forma information has not been prepared in accordance with Article 11 of Regulation S-X. This pro forma information is presented for illustrative purposes and is based on certain assumptions and judgments based on information available to us as of the date hereof, 나체사진 권소현 which may not necessarily have been applicable if the Shire acquisition had actually happened as of April 1, 2018. Moreover, this pro forma information gives effect to certain transactions and other events which are not directly attributable to the Shire acquisition and/or which happened subsequently to the 토토와프로토이야기 Thisacquisition, such as divestitures and the 나체사진 씨스타소유미니홈피 effects of the purchase price allocation for the Shire acquisition, and therefore may not accurately reflect GIRLSFORYOU 보배넷 the effect on our financial condition and results of operations if the Shire acquisition had actually been completed on April 1, 2018. Therefore, undue reliance should not be placed on 나체사진 애들은가라18 the GIRLSFORYOU pro forma information included herein.
[ii] Underlying growth compares two periods GIRLSFORYOU (quarters or years) of financial results under a common basis and is 나체사진 pornhat used by management 나체사진 해피투게더서우 to assess the business. These 스마트폰성인 [ii]results are calculated on GIRLSFORYOU Fap a constant currency basis and excluding the impact of divestitures and other amounts that are unusual, non-recurring items or 나체사진 야르시비 unrelated to our ongoing operations.
[iii] Underlying growth for the fiscal year ended March 31, 2020 versus the previous fiscal year ended March 31, 2019, pro-forma. The pro-forma baseline represents the sum of Takeda revenue GIRLSFORYOU 황정음노출화보 for the previous fiscal year (April 2018 to March 2019) plus Legacy Shire revenue from April 2018 나체사진 민효린란제리화보 through the acquisition date (January 8, 2019), both adjusted to remove the revenue from divested assets, with Legacy Shire revenue converted to JPY at the rate of 1 USD = 111 JPY 바카랏 [iii]FX 나체사진 속옷광고 rate for 나체사진 자놀 the previous fiscal year ended March 31, 여자핸드볼선수 [iii]and converted from US GAAP to IFRS with no material differences.
[iv] Core Operating Profit represents net profit adjusted to exclude income tax expenses, the share of profit GIRLSFORYOU 전효성배경화면 or loss of investments accounted for using the equity method, finance expenses and income, other operating expenses and income, amortization and impairment losses on acquired intangible assets and GIRLSFORYOU 체리넷 other 나체사진 딸자닷컴 items unrelated to 나체사진 적극성 Takeda’s core operations, such as purchase 타폭센 [iv]effects and transaction related costs.
[v] Underlying growth adjusts for divestitures (assets divested 나체사진 여유로움 in GIRLSFORYOU 밤가드 FY2019 부작용혈압 [v]disclosed lllilybaby [v]expected to close in FY2020) and applies a constant exchange 나체사진 텐프로미 rate (FY2019 full year average FX rate).
View source version on 손빨넷 View나체사진 Newswire 오나홀온라인판매판매쇼핑몰 Viewyour news across every 나체사진 따도녀 GIRLSFORYOU 따도녀 media 오마담 View나체사진 through GIRLSFORYOU 19Red the industry’s largest press release distribution network
|전화번호 :||영업시간 :|
|홈페이지 :||위치정보 :|
등록된 댓글이 없습니다.